Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22578931 | 0.80 | NAAA (0.41) | NAAAEPHX2HTTSMN1; SMN2TSHR | |
| SCHEMBL9943520 | 0.79 | NAAA (0.40) | NAAAEPHX2HTTSMN1; SMN2TSHR | |
| Phosphine SCHEMBL27538212 | 0.77 | EPHX1 (0.36) | TSHRNPSR1L3MBTL1EPHX1 | |
| SCHEMBL22592812 | 0.75 | NAAA (0.38) | NAAAEPHX2SMN1; SMN2TSHRNPSR1 | |
| SCHEMBL128491 | 0.75 | NAAA (0.57) | NAAAHTTNPSR1 | |
| SCHEMBL11218217 | 0.74 | ALDH1A1 (0.43) | TSHRMEN1KMT2AMAPTMAPK1 | |
| SCHEMBL2600809 | 0.74 | NAAA (0.73) | NAAAHTTTSHRNPSR1 | |
| SCHEMBL19497307 | 0.74 | NAAA (0.45) | NAAAEPHX2HTTMAPT | |
| SCHEMBL27488748 | 0.73 | EPHX2 (0.49) | NAAAEPHX2TSHRKMT2AL3MBTL1 | |
| SCHEMBL6564298 | 0.73 | L3MBTL1 (0.42) | TSHRKMT2ANPSR1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1067118-B1 | Cyclopentylalkyl-nitriles and the use of odoriferous cyclopentylalkyl derivatives as fragrances | GIVAUDAN SA (CH) | 2004-03-31 | — | — | EP | disclosed |
| US-6441052-B1 | ALKANOL, ALDEHYDE, AND KETONE CYCLOPENTA DERIVATIVES; FRAGRANCES | GIVAUDAN SA (CH) | 2002-08-27 | — | — | US | disclosed |
| US-20020086901-A1 | CYCLOPENTYLALKYL-NITRILES | GIVAUDAN SA, A SWITZERLAND CORPORATION | 2002-07-04 | — | — | US | disclosed |
| US-6410000-B1 | PERFUME | GIVAUDAN SA (CH) | 2002-06-25 | — | — | US | disclosed |
| US-6399811-B1 | ORGANOLEPTIC | GIVAUDAN SA (CH) | 2002-06-04 | — | — | US | disclosed |
| EP-1067118-A1 | Cyclopentylalkyl-nitriles and the use of odoriferous cyclopentylalkyl derivatives as fragrances | Givaudan SA (CH) | 2001-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020086901-A1 | CYCLOPENTYLALKYL-NITRILES | CCRL2, CBR1, CNR1 | NAAA 3074/4885EPHX2 325/4885HTT 4057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.